Search Results - Gil-Ares, F

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

    Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study) by Buti, M, Manzano, M.L, Morillas, R.M, García-Retortillo, M, Martín, L, Prieto, M, Gutiérrez, M.L, Suárez, E, Gil-Ares, F, López, J, Castillo, P, Rodríguez, M, Zozaya, J.M, Simón, M.A, Morano, L.E, Calleja, J.L, Esteban, R

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    THU-139 - Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

    THU-139 - Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study) by Buti, M., Manzano, M.L., Morillas, R.M., García-Retortillo, M., Martín, L., Prieto, M., Gutiérrez, M.L., Suárez, E., Gil-Ares, F., López, J., Castillo, P., Rodríguez, M., Zozaya, J.M., Simón, M.A., Morano, L.E., Calleja, J.L., Esteban, R.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: